ArticleBlood2023

Prospective validation of the prognostic relevance of CD34+CD38- AML stem cell frequency in the HOVON-SAKK132 trial.

Lok Lam Ngai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.